Multivariate analysis by Cox proportional hazards regression (Forward LR) model indicated that tumor size, mitotic rate, and risk grade were independent risk factors to OS for GISTs, and that ...

At present there is no established adjuvant treatment for GIST, but several ongoing studies have explored imatinib in the adjuvant setting. One study randomized patients to receive imatinib or ...

A recent study offering a comprehensive view of the genome and transcriptome of gastrointestinal stromal tumors (GISTs) has ...

GISTs, the most common type of sarcoma, display a fascinating range of aggressiveness. Unlike other sarcomas, GISTs can vary ...